Distinct genomic features between osteosarcomas firstly metastasing to bone and to lung

Background: Osteosarcoma initially metastasing to bone only shows distinct biological features compared to osteosarcoma that firstly metastasizes to the lung, which suggests us underlying different genomic pathogenetic mechanism. Methods: We analyzed whole-exome sequencing (WES) data for 38 osteosar...

Full description

Bibliographic Details
Main Authors: Lu Xie, Zhenyu Cai, Hezhe Lu, Fanfei Meng, Xin Zhang, Kun Luo, Xiaoxing Su, Yan Lei, Jiuhui Xu, Jingbing Lou, Han Wang, Zhiye Du, Yunfan Wang, Yuan Li, Tingting Ren, Jie Xu, Xin Sun, Xiaodong Tang, Wei Guo
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023027342
_version_ 1797815708008054784
author Lu Xie
Zhenyu Cai
Hezhe Lu
Fanfei Meng
Xin Zhang
Kun Luo
Xiaoxing Su
Yan Lei
Jiuhui Xu
Jingbing Lou
Han Wang
Zhiye Du
Yunfan Wang
Yuan Li
Tingting Ren
Jie Xu
Xin Sun
Xiaodong Tang
Wei Guo
author_facet Lu Xie
Zhenyu Cai
Hezhe Lu
Fanfei Meng
Xin Zhang
Kun Luo
Xiaoxing Su
Yan Lei
Jiuhui Xu
Jingbing Lou
Han Wang
Zhiye Du
Yunfan Wang
Yuan Li
Tingting Ren
Jie Xu
Xin Sun
Xiaodong Tang
Wei Guo
author_sort Lu Xie
collection DOAJ
description Background: Osteosarcoma initially metastasing to bone only shows distinct biological features compared to osteosarcoma that firstly metastasizes to the lung, which suggests us underlying different genomic pathogenetic mechanism. Methods: We analyzed whole-exome sequencing (WES) data for 38 osteosarcoma with paired samples in different relapse patterns. We also sought to redefine disease subclassifications for osteosarcoma based on genetic alterations and correlate these genetic profiles with clinical treatment courses to elucidate potential evolving cladograms. Results: We investigated WES of 12/38 patients with high-grade osteosarcoma (31.6%) with initial bone metastasis (group A) and 26/38 (68.4%) with initial pulmonary metastasis (group B), of whom 15/38 (39.5%) had paired samples of primary lesions and metastatic lesions. We found that osteosarcoma in group A mainly carries single-nucleotide variations displaying higher tumor mutation burden and neoantigen load and more tertiary lymphoid structures, while those in group B mainly exhibits structural variants. High conservation of reported genetic sequencing over time in their evolving cladograms. Conclusions: Osteosarcoma with mainly single-nucleotide variations other than structural variants might exhibit biological behavior predisposing toward bone metastases as well as better immunogenicity in tumor microenvironment.
first_indexed 2024-03-13T08:26:46Z
format Article
id doaj.art-629030ab3c324f20982b605f7659eee1
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-13T08:26:46Z
publishDate 2023-05-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-629030ab3c324f20982b605f7659eee12023-05-31T04:44:41ZengElsevierHeliyon2405-84402023-05-0195e15527Distinct genomic features between osteosarcomas firstly metastasing to bone and to lungLu Xie0Zhenyu Cai1Hezhe Lu2Fanfei Meng3Xin Zhang4Kun Luo5Xiaoxing Su6Yan Lei7Jiuhui Xu8Jingbing Lou9Han Wang10Zhiye Du11Yunfan Wang12Yuan Li13Tingting Ren14Jie Xu15Xin Sun16Xiaodong Tang17Wei Guo18Musculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, ChinaMusculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, ChinaState Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, No. A3 Datun Road, Chaoyang District, Beijing 100101, ChinaShanghai OrigiMed Co., Ltd, Shanghai, No. 3576 Zhaolou Road, Minhang District, Shanghai, 201112, ChinaShanghai OrigiMed Co., Ltd, Shanghai, No. 3576 Zhaolou Road, Minhang District, Shanghai, 201112, ChinaShanghai OrigiMed Co., Ltd, Shanghai, No. 3576 Zhaolou Road, Minhang District, Shanghai, 201112, ChinaBerry Oncology Corporation, Fuzhou, 350200, ChinaBerry Oncology Corporation, Fuzhou, 350200, ChinaMusculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, ChinaMusculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, ChinaMusculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, ChinaMusculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, ChinaPathology Department, Peking University Shougang Hospital, No. 9 Jinyuanzhuang Road, Shijingshan District, Beijing, 100144, ChinaRadiology Department & Nuclear Medicine Department, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, ChinaMusculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, ChinaMusculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, ChinaMusculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, ChinaMusculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, China; Corresponding author.Musculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, China; Corresponding author.Background: Osteosarcoma initially metastasing to bone only shows distinct biological features compared to osteosarcoma that firstly metastasizes to the lung, which suggests us underlying different genomic pathogenetic mechanism. Methods: We analyzed whole-exome sequencing (WES) data for 38 osteosarcoma with paired samples in different relapse patterns. We also sought to redefine disease subclassifications for osteosarcoma based on genetic alterations and correlate these genetic profiles with clinical treatment courses to elucidate potential evolving cladograms. Results: We investigated WES of 12/38 patients with high-grade osteosarcoma (31.6%) with initial bone metastasis (group A) and 26/38 (68.4%) with initial pulmonary metastasis (group B), of whom 15/38 (39.5%) had paired samples of primary lesions and metastatic lesions. We found that osteosarcoma in group A mainly carries single-nucleotide variations displaying higher tumor mutation burden and neoantigen load and more tertiary lymphoid structures, while those in group B mainly exhibits structural variants. High conservation of reported genetic sequencing over time in their evolving cladograms. Conclusions: Osteosarcoma with mainly single-nucleotide variations other than structural variants might exhibit biological behavior predisposing toward bone metastases as well as better immunogenicity in tumor microenvironment.http://www.sciencedirect.com/science/article/pii/S2405844023027342OsteosarcomaMetastasesSingle-nucleotide variation (SNV)Structural variation (SV)
spellingShingle Lu Xie
Zhenyu Cai
Hezhe Lu
Fanfei Meng
Xin Zhang
Kun Luo
Xiaoxing Su
Yan Lei
Jiuhui Xu
Jingbing Lou
Han Wang
Zhiye Du
Yunfan Wang
Yuan Li
Tingting Ren
Jie Xu
Xin Sun
Xiaodong Tang
Wei Guo
Distinct genomic features between osteosarcomas firstly metastasing to bone and to lung
Heliyon
Osteosarcoma
Metastases
Single-nucleotide variation (SNV)
Structural variation (SV)
title Distinct genomic features between osteosarcomas firstly metastasing to bone and to lung
title_full Distinct genomic features between osteosarcomas firstly metastasing to bone and to lung
title_fullStr Distinct genomic features between osteosarcomas firstly metastasing to bone and to lung
title_full_unstemmed Distinct genomic features between osteosarcomas firstly metastasing to bone and to lung
title_short Distinct genomic features between osteosarcomas firstly metastasing to bone and to lung
title_sort distinct genomic features between osteosarcomas firstly metastasing to bone and to lung
topic Osteosarcoma
Metastases
Single-nucleotide variation (SNV)
Structural variation (SV)
url http://www.sciencedirect.com/science/article/pii/S2405844023027342
work_keys_str_mv AT luxie distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT zhenyucai distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT hezhelu distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT fanfeimeng distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT xinzhang distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT kunluo distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT xiaoxingsu distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT yanlei distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT jiuhuixu distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT jingbinglou distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT hanwang distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT zhiyedu distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT yunfanwang distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT yuanli distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT tingtingren distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT jiexu distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT xinsun distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT xiaodongtang distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung
AT weiguo distinctgenomicfeaturesbetweenosteosarcomasfirstlymetastasingtoboneandtolung